AI, Healthcare, and 700 Million Patients | Ni...

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. ...  Show more

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ...  Show more

Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ...  Show more

How will we detect disease in the future, and how might new technology aid our well-being? In this episode, Dr. Oz sits down with entrepreneur Peter Diamandis and former FDA commissioner Rob Califf inside The Vatican to uncover the truth about the future of medicine. From the lat ...  Show more

Vijay Pande, founding general partner, and Julie Yoo, general partner at a16z Bio + Health, come together to discuss the grand challenges facing healthcare AI today.

The talk through the implications of AI integration in healthcare workflows, AI as a potential catalyst f ...

In this episode, Marc Andreessen and Vijay Pande discuss expert AI and its role in healthcare, bio, and more.

Watch on Youtube: https://youtu.be/c7ScUDYSRYo

Subscribe to Bio Eats World: <a href="https://podcasts.ap ...